Menjugate meningitis C vaccine

Menjugate meningitis C vaccine

M715/0609 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 58.0MB

Downloadable file size: 2.5MB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only

Caption: Menjugate meningitis C vaccine. Menjugate contains inactivated extracts from the bacteria that cause meningitis C (Neisseria meningitidis group C). When injected, the vaccine stimulates the body's immune system to produce antibodies, but without causing an infection. The immune system can then respond quickly to future infections by the bacteria. The meningococcal group C vaccine is given as two separate doses, at three and four months of age. The child will then be given a booster dose at twelve months, in combination with a Hib booster.

Release details: Model release not required. Property release not required.

Keywords: bacteria, bacterial, bacterium, biological, childhood, conjugate, container, drug, extracts, group c, immunisation, immunity, immunization, inactivated, injection, inoculation, jar, medical, medicine, meningitis, meningitis c, meningococcal, menjugate, neisseria meningitidis, one, packaging, pharmacological, pharmacology, phial, preventative, prevention, prophylactic, prophylaxis, protection, protective, single, vaccination, vaccine, vial

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.